会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 31. 发明授权
    • Liquid crystal composition
    • 液晶组成
    • US06372308B1
    • 2002-04-16
    • US09521956
    • 2000-03-09
    • Yasue YoshiokaMasahiro JohnoTomoyuki YuiTakahiro Matsumoto
    • Yasue YoshiokaMasahiro JohnoTomoyuki YuiTakahiro Matsumoto
    • C09K1912
    • C09K19/0266C09K19/2021Y10T428/10
    • A liquid crystal composition includes (1) an anti-ferroelectric liquid crystal compound of formula (1) and (2) a ferrielectric liquid crystal compound or racemic compound thereof. The composition ratio of (1) to (2) is in the range extending from a value which extends from within 5 mol % of the boundary compositional ratio on the anti-ferroelectric phase side and to within 25 mol % of the boundary compositional ratio on the ferrielectric phase side. The boundary compositional ratio is obtained on the basis of a liquid crystal phase diagram prepared on the basis of conoscopic image observations obtained by changing the mixing ratio of (1) and (2). The liquid crystal composition has the following properties: (b) an optical response in a positive voltage region and a negative voltage region and free or substantially free of hysteresis; and (c) excellent alignment stability. The liquid crystal composition is substantially free from sticking, is excellent in alignment and alignment stability and exhibits a V-letter-shaped optical response so that it can be used in a highly reliable active matrix liquid crystal display device.
    • 液晶组合物包括(1)式(1)的反铁电液晶化合物和(2)电介质液晶化合物或其外消旋化合物。 (1)〜(2)的组成比在从反铁电相侧的边界成分比例的5摩尔%以内的值延伸到边界成分比的25摩尔%以下的范围内 电介质相侧。 基于通过改变(1)和(2)的混合比获得的虹膜图像观察准备的液晶相图获得边界组成比。 液晶组合物具有以下性质:(b)在正电压区域和负电压区域中的光学响应,并且具有自由或基本上没有迟滞; 和(c)极好的取向稳定性。 液晶组合物基本上没有粘附,对准和取向稳定性优异,呈V字形的光学响应,因此可用于高可靠性的有源矩阵液晶显示装置。
    • 32. 发明授权
    • Exposure apparatus and method
    • 曝光装置和方法
    • US06151120A
    • 2000-11-21
    • US198443
    • 1998-11-24
    • Takahiro MatsumotoHideki Ina
    • Takahiro MatsumotoHideki Ina
    • G03F7/20G03F9/00H01L21/027G01B11/00
    • G03F9/7084G03F9/7049
    • In this exposure apparatus, a wafer formed with a first alignment mark and a mask formed with a second alignment mark at a position outside the exposure field angle are aligned. The exposure apparatus includes an alignment detection system for optically detecting any positional deviation between the first and second alignment marks, a calculator for calculating any positional deviation between a first pattern formed on the wafer and a second pattern formed on the mask on the basis of the detection result of the alignment detection system, the position of the first alignment mark in the wafer, and the position of the second alignment mark in the mask, and an actuator for driving a wafer stage on the basis of the calculation result of the calculator to make the first and second patterns overlap each other.
    • 在该曝光装置中,对准具有第一对准标记的晶片和在曝光视场角外的位置处形成有第二对准标记的掩模。 曝光装置包括用于光学检测第一和第二对准标记之间的任何位置偏差的对准检测系统,用于计算形成在晶片上的第一图案与形成在掩模上的第二图案之间的任何位置偏差的计算器, 对准检测系统的检测结果,晶片中的第一对准标记的位置和掩模中的第二对准标记的位置,以及基于计算器的计算结果驱动晶片台的致动器 使第一和第二模式彼此重叠。
    • 37. 发明授权
    • Intraocular irrigating and enucleated eyeball preservative composition
    • 眼内灌注和去核眼球防腐剂组成
    • US5500445A
    • 1996-03-19
    • US197325
    • 1994-02-16
    • Takahiro MatsumotoShogo SameshimaKenichi Yoshida
    • Takahiro MatsumotoShogo SameshimaKenichi Yoshida
    • A61K9/00A61K31/665A61K31/34
    • A61K31/665A61K9/0048Y10S514/912
    • This invention relates to an intraocular irrigating and enucleated eyeball preservative composition containing a phosphoric acid diester compound of the following formula or a pharmacologically acceptable salt thereof ##STR1## wherein R.sub.1 and R.sub.2 are the same or different and each represents a hydrogen atom or a methyl group.The composition of this invention is highly lenient to the ocular tissues, particularly in the sense that it protects the corneal (endothelial) cells which are most susceptible to physiological damage in ophthalmic surgery, with the result that various ophthalmic operations can be carried out with sufficient safety. Furthermore, since the composition of this invention may help retain the physiological functions of the enucleated eyeball without injuring its tissues, it can be used with advantage for the preservation of the cornea, retina, crystalline lens and so on.
    • 本发明涉及含有下式的磷酸二酯化合物或其药理学上可接受的盐的眼内注射和去核眼球防腐剂组合物,其中R 1和R 2相同或不同,各自表示氢原子或甲基 。 本发明的组合物对于眼组织是高度宽松的,特别是在保护在眼科手术中最容易受到生理损伤的角膜(内皮)细胞的意义上,结果是可以充分地进行各种眼科手术 安全。 此外,由于本发明的组合物可有助于保持去核眼球的生理功能而不损伤其组织,所以可以有利地用于保存角膜,视网膜,晶状体等。